VolitionRx Limited (VNRX) Return on equity 2019–2021
VolitionRx Limited (VNRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-152.3%FY2021 · since FY2019: -113.4% → -152.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -152.3% | -27.1 pp |
| FY2020 | -125.2% | -11.8 pp |
| FY2019 | -113.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VNRX financial trends
VNRX RevenueVNRX Net incomeVNRX Net marginVNRX Gross profitVNRX Gross marginVNRX Operating incomeVNRX Operating marginVNRX Operating cash flowVNRX Free cash flowVNRX Capital expendituresVNRX Stock buybacksVNRX Dividends paidVNRX Total assetsVNRX Total liabilitiesVNRX Shareholders’ equityVNRX overview →